Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by fezguy


PMN

More from Eden Rahim on Promis’s promise:

http://www.cantechletter.com/2016/08/rise-small-cap-biotech-signals-return...

August 5, 2016

PMN

New article on Promis

This out today: http://www.stockhouse.com/news/newswire/2016/05/31/promis...

May 31, 2016

PMN

Amorfix still able to raise money

http://finance.yahoo.com/news/amorfix-closes-private-placement-receives...

October 21, 2014

PMN

Amorfix granted new US patent 4/29

Amorfix granted new US patent regarding misfolded-SOD1: http://www.otcmarkets...

May 2, 2014

PMN

Reviewer of Neil Cashman’s PNAS report is Stanley Prusiner

Note that reviewer of Neil Cashman’s PNAS report is Stanley Prusiner...

February 20, 2014

PMN

Amorfix Instablog

Here’s a recent Instablog post re Amorfix on SA: http://seekingalpha.com/user...

August 27, 2013

T.CTH

RE: Looks Promising

Here’s a brief video clip with the Cynapsus CEO http...

June 6, 2013

T.CTH

Zacks rates Cynapsus a Buy

Zacks rates Cynapsus a Buy with a $1.25 target price: http://finance.yahoo...

June 6, 2013

PMN

RE: Prothena connection

In case folks missed this: http://www.stockhouse.com/bullboards/messagedetail...

January 7, 2013

PMN

Dr. Cashman is on Prothena SAB

Dr. Cashman is on scientific advisory board of Prothena, newly traded spinoff...

December 27, 2012

NPCUF

RE: RE: Kickinghorse

OPTSALES2: PPHM never got FDA approval. They reported positive trial results...

December 11, 2012

ABUS

RE: SEC Filing by Working Opportunity Fund

Tekmira should buy the Growth Works/Working Opportunity fund shares...

December 6, 2012

ABUS

SEC Filing by Working Opportunity Fund

SEC Filing by Working Opportunity Fund. They still own 8.3%. http...

November 29, 2012

PMN

Dementia article

Dementia article worth reading; http://www.technologyreview.com/featured...

October 11, 2012

ABUS

Desjardins new TKM target C$6.30

Desjardins raises Tekmira Pharmaceuticals Corp price target to C$6.30 from C...

August 15, 2012

V.ICAU.H

Northcliff shres

Has anyone received their Northcliff shares?

July 23, 2012

PMN

RE: SO what about Interinvest

The private acquisitions and sales are virtually all share transfers from one...

June 30, 2012

PMN

RE: Briton cured in CJD drug trial

Unfortunately, Rachel died in 2001. http://www.guardian.co.uk/uk/2001/dec/02...

June 26, 2012

PMN

Prions in the news!

http://www.sciencenews.org/view/generic/id/341619/title/Like_a_prion...

June 22, 2012

V.ZC

Zimtu Insider Buying

Filing Date Transaction Date Insider Name Ownership ...

May 22, 2012

1 2 3 Next

Featured Company